Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹7 Cr
Revenue (TTM)
₹1 Cr
Net Profit (TTM)
₹0 Cr
ROE
-0.3 %
ROCE
-0.2 %
P/E Ratio
--
P/B Ratio
0.7
Industry P/E
45.87
EV/EBITDA
83.1
Div. Yield
0 %
Debt to Equity
0.1
Book Value
₹--
EPS
₹-0
Face value
10
Shares outstanding
15,099,952
CFO
₹-0.31 Cr
EBITDA
₹-7.22 Cr
Net Profit
₹-2.76 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dolphin Medical
| 62.0 | 27.4 | 69.7 | 103.9 | 41.3 | 22.4 | 15.2 |
|
BSE Healthcare*
| -2.3 | -4.5 | -3.3 | 2.4 | 25.3 | 15.4 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dolphin Medical
| 0.3 | 39.5 | 12.0 | -36.8 | 41.3 | 400.0 | -51.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dolphin Medical
|
4.7 | 7.0 | 0.7 | 0.0 | -5.6 | -0.1 | -- | 0.7 |
| 668.0 | 34,525.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 105.6 | 7.5 | |
| 409.8 | 12,973.3 | 1,976.2 | 160.7 | 14.1 | 6.7 | 102.9 | 6.6 | |
| 531.8 | 7,928.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 418.4 | 5.9 | |
| 385.3 | 3,528.0 | 1,451.5 | 182.9 | 15.5 | 29.2 | 19.3 | 5.0 | |
| 1,279.5 | 8,367.9 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.4 | 5.6 | |
| 5,127.9 | 5,611.0 | 1,529.9 | 235.8 | 21.2 | 20.7 | 23.8 | 4.5 | |
| 200.0 | 8,634.3 | 1,393.6 | 213.2 | -- | 22.1 | 42.1 | 4.6 | |
| 1,164.4 | 11,815.9 | 1,613.3 | 259.9 | 23.0 | 17.3 | 45.9 | 7.4 | |
| 642.3 | 6,186.9 | 1,089.4 | 165.1 | 17.4 | 10.2 | 37 | 3.6 |
No Review & Analysis are available.
Dolphin Medical Services Limited provides medical laboratory services in India. The company operates ophthalmic laser care centre providing to which provides laser eye treatment under Dolphin Nethralaya name; offers teleradiology services; and... distributes medical equipment and goods. It also provides foods and herbal products, and electronic solution and technologies, as well as clinical trials and life sciences services. The company was incorporated in 1992 and is based in Vijayawada, India. Read more
Incorporated
1992
Chairman
--
Managing Director
G V Mohan Prasad
Headquarters
Rangareddy, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Dolphin Medical Services Ltd is ₹4.65 (BSE) as of 23-Mar-2026 IST. Dolphin Medical Services Ltd has given a return of 41.25% in the last 3 years.
Since, TTM earnings of Dolphin Medical Services Ltd is negative, P/E ratio is not available.
The P/B ratio of Dolphin Medical Services Ltd is 0.70 times as on 23-Mar-2026, a 89 discount to its peers’ median range of 6.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.34
|
|
2024
|
0.00
|
0.40
|
|
2023
|
0.00
|
0.23
|
|
2022
|
0.00
|
0.29
|
|
2021
|
0.00
|
0.21
|
The 52-week high and low of Dolphin Medical Services Ltd are Rs 4.65 and Rs 1.98 as of 28-Mar-2026.
Dolphin Medical Services Ltd has a market capitalisation of ₹ 7 Cr as on 23-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dolphin Medical Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.22
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.